Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

-
September 4, 2019
Spago Nanomedical

Increased use of medical imaging in North America

Peter Hartman spoke to Rapidus about investment promotion and the new joint microbiome project with Copenhagen Capacity and Invbest in Skåne.

Increased use of medical imaging in North America

According to a study recently published in Journal of American Medical Association and cited by the web based radiology news channel AuntMinnie, use of MRI continue to rise in North America.

The study implies medical imaging is generally considered beneficial by treating physicians in USA and Canada. It is also clear there is awareness of benefits of MRI (e.g. no radiation exposure) but need for more precision in imaging diagnosis.

Spago Nanomedical´s project SpagoPix holds potential to increase specificity in diagnosis of solid tumors, such as breast cancer.

Last updated:
September 23, 2019

Spago Nanomedical

Spago Nanomedical AB is a Swedish company performing research and development within nanomedicine. Focus is the development of nanomaterials for tumor diagnostics and treatment of cancer. The main development projects SpagoPix and Tumorad are both built on proprietary nanomaterials

Click here to read more about us!
Get in touch with us!
Visit us

Scheelevägen 22
SE-223 63 Lund
Sweden

Send us mail

According to a study recently published in Journal of American Medical Association and cited by the web based radiology news channel AuntMinnie, use of MRI continue to rise in North America.

The study implies medical imaging is generally considered beneficial by treating physicians in USA and Canada. It is also clear there is awareness of benefits of MRI (e.g. no radiation exposure) but need for more precision in imaging diagnosis.

Spago Nanomedical´s project SpagoPix holds potential to increase specificity in diagnosis of solid tumors, such as breast cancer.

Last updated:
September 23, 2019

Spago Nanomedical

Spago Nanomedical AB is a Swedish company performing research and development within nanomedicine. Focus is the development of nanomaterials for tumor diagnostics and treatment of cancer. The main development projects SpagoPix and Tumorad are both built on proprietary nanomaterials

Click here to read more about us!
Get in touch with us!
Visit us

Scheelevägen 22
SE-223 63 Lund
Sweden

Send us mail